EPIX
Price
$1.91
Change
+$0.03 (+1.60%)
Updated
Aug 7, 04:26 PM (EDT)
Capitalization
82.91M
138 days until earnings call
GANX
Price
$1.49
Change
-$0.05 (-3.25%)
Updated
Aug 7, 04:35 PM (EDT)
Capitalization
53.41M
Earnings call today
Interact to see
Advertisement

EPIX vs GANX

Header iconEPIX vs GANX Comparison
Open Charts EPIX vs GANXBanner chart's image
ESSA Pharma
Price$1.91
Change+$0.03 (+1.60%)
Volume$200
Capitalization82.91M
Gain Therapeutics
Price$1.49
Change-$0.05 (-3.25%)
Volume$2.3K
Capitalization53.41M
EPIX vs GANX Comparison Chart in %
Loading...
EPIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EPIX vs. GANX commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPIX is a Hold and GANX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (EPIX: $1.87 vs. GANX: $1.54)
Brand notoriety: EPIX and GANX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EPIX: 274% vs. GANX: 88%
Market capitalization -- EPIX: $82.91M vs. GANX: $53.41M
EPIX [@Biotechnology] is valued at $82.91M. GANX’s [@Biotechnology] market capitalization is $53.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $210.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EPIX’s FA Score shows that 1 FA rating(s) are green whileGANX’s FA Score has 0 green FA rating(s).

  • EPIX’s FA Score: 1 green, 4 red.
  • GANX’s FA Score: 0 green, 5 red.
According to our system of comparison, EPIX is a better buy in the long-term than GANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EPIX’s TA Score shows that 4 TA indicator(s) are bullish while GANX’s TA Score has 4 bullish TA indicator(s).

  • EPIX’s TA Score: 4 bullish, 5 bearish.
  • GANX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both EPIX and GANX are a bad buy in the short-term.

Price Growth

EPIX (@Biotechnology) experienced а -0.53% price change this week, while GANX (@Biotechnology) price change was +3.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.96%. For the same industry, the average monthly price growth was +8.28%, and the average quarterly price growth was +12.24%.

Reported Earning Dates

EPIX is expected to report earnings on Dec 23, 2025.

GANX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+0.96% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EPIX($82.9M) has a higher market cap than GANX($53.4M). EPIX YTD gains are higher at: 4.469 vs. GANX (-28.472). GANX has higher annual earnings (EBITDA): -20.26M vs. EPIX (-27.4M). EPIX has more cash in the bank: 114M vs. GANX (9.07M). EPIX has less debt than GANX: EPIX (280K) vs GANX (607K). EPIX (0) and GANX (0) have equivalent revenues.
EPIXGANXEPIX / GANX
Capitalization82.9M53.4M155%
EBITDA-27.4M-20.26M135%
Gain YTD4.469-28.472-16%
P/E RatioN/AN/A-
Revenue00-
Total Cash114M9.07M1,257%
Total Debt280K607K46%
FUNDAMENTALS RATINGS
EPIX: Fundamental Ratings
EPIX
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
12

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EPIXGANX
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 7 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
EPIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TDHOY13.310.50
+3.93%
T&D Holdings, Inc.
EMITF1.85N/A
N/A
Elbit Imaging, Ltd.
UEPCO97.00N/A
N/A
Union Electric Co.
IWGFF2.96-0.04
-1.33%
IWG PLC
NSRCF0.35-0.04
-9.61%
Nextsource Materials Inc.

EPIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EPIX has been loosely correlated with LXRX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if EPIX jumps, then LXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPIX
1D Price
Change %
EPIX100%
-1.06%
LXRX - EPIX
34%
Loosely correlated
+9.52%
ELAB - EPIX
32%
Poorly correlated
+2.14%
PCVX - EPIX
31%
Poorly correlated
-2.16%
GANX - EPIX
28%
Poorly correlated
-7.49%
MREO - EPIX
27%
Poorly correlated
-2.45%
More

GANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GANX has been loosely correlated with AXON. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if GANX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GANX
1D Price
Change %
GANX100%
-7.49%
AXON - GANX
36%
Loosely correlated
-0.40%
MDGL - GANX
34%
Loosely correlated
-0.24%
ARRY - GANX
34%
Loosely correlated
-3.05%
COYA - GANX
34%
Loosely correlated
-0.47%
OCUL - GANX
33%
Poorly correlated
+4.17%
More